Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.
Telitacicept, a new dual inhibitor of the cytokines B-lymphocyte stimulator (BLyS) and APRIL (a proliferation-inducing ligand ...
The company is selling the rights to a drug candidate aimed at rare blood and kidney disorders.
The deal gives Novo rights to a drug it sees as having "multiple advantages" over other treatments for so-called ...
Danish drugmaker Novo Nordisk and Omeros have signed a licensing deal worth up to $2.1 billion for the U.S.-based company's ...
3don MSN
Novartis Receives FDA Approval for Rhapsido (remibrutinib) for Chronic Spontaneous Urticaria
Novartis (NYSE:NVS) is one of the best growth stocks to buy now. On September 30, Novartis announced the US FDA approval of ...
Blue Heat, Safe-T-Salt, Snow Joe, Ice Slicer. These snappy brand names are pretty much all you have to go on when choosing an ice melt, leaving no sign of whether they’ll damage the concrete, harm ...
You can use neti pots like bulb syringes, squeeze bottles, and pulsed water devices to flush out your sinuses.
Novartis has entered into a grant agreement with the Bill & Melinda Gates Foundation to fund the development of accessible single use gene therapies to cure sickle cell disease (SCD), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback